Terms: = Germ cell tumor AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha AND Clinical Outcome
13 results:
1. Hypoxia-induced GLT8D1 promotes glioma stem cell maintenance by inhibiting CD133 degradation through N-linked glycosylation.
Liu K; Jiang L; Shi Y; Liu B; He Y; Shen Q; Jiang X; Nie Z; Pu J; Yang C; Chen Y
Cell Death Differ; 2022 Sep; 29(9):1834-1849. PubMed ID: 35301431
[TBL] [Abstract] [Full Text] [Related]
2. Inhibition of lysine-specific demethylase LSD1 induces senescence in Glioblastoma cells through a HIF-1α-dependent pathway.
Saccà CD; Gorini F; Ambrosio S; Amente S; Faicchia D; Matarese G; Lania L; Majello B
Biochim Biophys Acta Gene Regul Mech; 2019 May; 1862(5):535-546. PubMed ID: 30951900
[TBL] [Abstract] [Full Text] [Related]
3. Increased expression of hypoxia-inducible factor-1 alpha and its impact on transcriptional changes and prognosis in malignant tumours of the ocular adnexa.
Lange CAK; Lehnert P; Boneva SK; Zhang P; Ludwig F; Boeker M; Hoffmeier K; Horres R; Schlunck G; Reinhard T; Böhringer D; Auw-Haedrich C
Eye (Lond); 2018 Nov; 32(11):1772-1782. PubMed ID: 30065361
[TBL] [Abstract] [Full Text] [Related]
4. Hypoxia-induced PLOD2 promotes proliferation, migration and invasion via PI3K/Akt signaling in glioma.
Song Y; Zheng S; Wang J; Long H; Fang L; Wang G; Li Z; Que T; Liu Y; Li Y; Zhang X; Fang W; Qi S
Oncotarget; 2017 Jun; 8(26):41947-41962. PubMed ID: 28410212
[TBL] [Abstract] [Full Text] [Related]
5. HIF-1α genetic variants and protein expression confer the susceptibility and prognosis of gliomas.
Yi L; Hou X; Zhou J; Xu L; Ouyang Q; Liang H; Zheng Z; Chen H; Xu M
Neuromolecular Med; 2014 Sep; 16(3):578-86. PubMed ID: 24929654
[TBL] [Abstract] [Full Text] [Related]
6. β-Carotene inhibits neuroblastoma cell invasion and metastasis in vitro and in vivo by decreasing level of hypoxia-inducible factor-1α.
Kim YS; Lee HA; Lim JY; Kim Y; Jung CH; Yoo SH; Kim Y
J Nutr Biochem; 2014 Jun; 25(6):655-64. PubMed ID: 24746828
[TBL] [Abstract] [Full Text] [Related]
7. Increased HIF-1α expression correlates with cell proliferation and vascular markers CD31 and VEGF-A in uveal melanoma.
Mouriaux F; Sanschagrin F; Diorio C; Landreville S; Comoz F; Petit E; Bernaudin M; Rousseau AP; Bergeron D; Morcos M
Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1277-83. PubMed ID: 24481264
[TBL] [Abstract] [Full Text] [Related]
8. Topotecan inhibits vascular endothelial growth factor production and angiogenic activity induced by hypoxia in human neuroblastoma by targeting hypoxia-inducible factor-1alpha and -2alpha.
Puppo M; Battaglia F; Ottaviano C; Delfino S; Ribatti D; Varesio L; Bosco MC
Mol Cancer Ther; 2008 Jul; 7(7):1974-84. PubMed ID: 18645007
[TBL] [Abstract] [Full Text] [Related]
9. Involvement of HIF-1 in invasion of Mum2B uveal melanoma cells.
Victor N; Ivy A; Jiang BH; Agani FH
Clin Exp Metastasis; 2006; 23(1):87-96. PubMed ID: 16826425
[TBL] [Abstract] [Full Text] [Related]
10. Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1alpha in neuroblastoma cells.
Nakamura K; Martin KC; Jackson JK; Beppu K; Woo CW; Thiele CJ
Cancer Res; 2006 Apr; 66(8):4249-55. PubMed ID: 16618748
[TBL] [Abstract] [Full Text] [Related]
11. Topotecan blocks hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression induced by insulin-like growth factor-I in neuroblastoma cells.
Beppu K; Nakamura K; Linehan WM; Rapisarda A; Thiele CJ
Cancer Res; 2005 Jun; 65(11):4775-81. PubMed ID: 15930297
[TBL] [Abstract] [Full Text] [Related]
12. Hypoxia-inducible factor 1alpha/vascular endothelial growth factor axis in astrocytomas. Associations with microvessel morphometry, proliferation and prognosis.
Korkolopoulou P; Patsouris E; Konstantinidou AE; Pavlopoulos PM; Kavantzas N; Boviatsis E; Thymara I; Perdiki M; Thomas-Tsagli E; Angelidakis D; Rologis D; Sakkas D
Neuropathol Appl Neurobiol; 2004 Jun; 30(3):267-78. PubMed ID: 15175080
[TBL] [Abstract] [Full Text] [Related]
13. Vascular patterns in glioblastoma influence clinical outcome and associate with variable expression of angiogenic proteins: evidence for distinct angiogenic subtypes.
Birner P; Piribauer M; Fischer I; Gatterbauer B; Marosi C; Ambros PF; Ambros IM; Bredel M; Oberhuber G; Rössler K; Budka H; Harris AL; Hainfellner JA
Brain Pathol; 2003 Apr; 13(2):133-43. PubMed ID: 12744467
[TBL] [Abstract] [Full Text] [Related]
